Sulphonylurea monotherapy may be associated with a significantly greater risk of cancer-related mortality than metformin ± sulphonylureas

Author：  

Publisher： Adis International

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1060, 2005-01, pp. : 5-5

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Metformin may reduce the risk of cancer in patients with type 2 diabetes mellitus

By  

Inpharma, Vol. 1, Iss. 1491, 2005-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite

Inappropriate -blocker prescribing after acute myocardial infarction (MI) is associated with greater mortality than appropriate prescribing

By  

Inpharma, Vol. 1, Iss. 1511, 2005-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Prostate cancer-related psychosocial morbidity worse for partners than for patients

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 297, 2001-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Selective COX-2 inhibitors may pose a greater risk of hyperkalaemia than nonselective NSAIDs

By  

Reactions Weekly, Vol. 1, Iss. 1325, 2010-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Metformin therapy is associated with reduced cardiovascular morbidity and mortality

By  

Inpharma, Vol. 1, Iss. 1491, 2005-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite